Brooks Laboratories Ltd Quarterly Results

Gross Sales

23.45

25.51

23.32

20.52

20.79

Excise Duty

0

0

0

0

0

Net Sales

23.45

25.51

23.32

20.52

20.79

Other Operating Income

0

0

0

0

0

Other Income

6.13

7.15

0.62

0.03

0.2

Total Income

29.58

32.66

23.94

20.54

20.99

Total Expenditure

20.93

22.39

24.57

22.01

24.2

PBIDT

8.65

10.28

-0.63

-1.46

-3.21

Interest

0.28

0.3

0.26

0.28

0.32

PBDT

8.37

9.98

-0.9

-1.75

-3.53

Depreciation

0.39

0.39

0.39

0.38

0.43

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0.18

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

7.98

9.58

-1.46

-2.13

-3.96

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

7.98

9.58

-1.46

-2.13

-3.96

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

7.98

9.58

-1.46

-2.13

-3.96

EPS (Unit Curr.)

2.71

3.25

-0.54

-1.75

-1.51

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

29.46

29.46

29.46

26.25

26.25

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.88

40.29

-2.7

-7.11

-15.44

PBDTM(%)

35.69

39.12

-3.85

-8.52

-16.97

PATM(%)

34.02

37.55

-6.26

-10.38

-19.04